Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands

被引:51
作者
Gibbons, MD
Manne, U
Carroll, WR
Peters, GE
Weiss, HL
Grizzle, WE
机构
[1] Univ Alabama Birmingham, Div Otolaryngol Head & Neck Surg, Dept Surg, Birmingham, AL 35249 USA
[2] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35249 USA
[3] Univ Alabama Birmingham, Biostat Unit, Birmingham Comprehens Canc Ctr, Birmingham, AL 35249 USA
关键词
major salivary gland tumors; erbB-2; erbB-3; epidermal growth factor receptor; transforming growth factor-alpha;
D O I
10.1097/00005537-200108000-00011
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective/Hypothesis. Mucoepidermoid carcinoma (MEC) and adenoid cystic carcinoma (ACC), the most common malignancies of the major salivary glands, are clinically and pathologically different. To determine whether MEC and ACC have different molecular characteristics, we examined the expression of erbB-2, erbB-3, epidermal growth factor receptor (EGFR), and transforming growth factor-alpha (TGF-alpha), important molecular features in other malignancies. Study Design/Methods. Archival tissue sections of 22 MEC and 6 ACC tumors of the major salivary glands were evaluated immunohistochemically for expression of erbB-2, erbB-3, EGRF, and TGF-alpha. A differential immunostaining score, reflecting the difference in immunostaining between carcinoma and uninvolved salivary gland tissue, was calculated for cytoplasmic and membranous staining. Results. Positive immunostaining for all biomarkers was observed in the cytoplasm and membrane of both tumors. However, expression was higher in MEC than in ACC tumors and was statistically significant for cytoplasmic EGFR (P =.009), TGF-alpha (P =.041), and membranous EGFR (P =.004). A significantly higher percentage of MEC cells also demonstrated positive immunostaining for cytoplasmic erbB-3 (P =.022), EGFR (P =.005), membranous erbB-3 (P =.022), and EGFR (P =.013). The differential immunostaining score was significantly higher for MEC compared with uninvolved alveolar tissue and the membranes of uninvolved ductal tissue. There were no statistically positive differential immunostaining scores for ACC. Conclusions. There is a clear difference in the molecular phenotypes of MEC and ACC. The lack of statistically significant expression in ACC, when compared with similar uninvolved. salivary gland tissue, suggests minimal involvement for these molecular structures in the pathogenesis of ACC. Conversely, erbB-2, erbB-3, EGFR, and TGF-alpha may have a role in the development and progression of MEC. These results have therapeutic implications for MEC of the major salivary glands.
引用
收藏
页码:1373 / 1378
页数:6
相关论文
共 40 条
[1]  
Cho KJ, 1999, HEAD NECK-J SCI SPEC, V21, P414
[2]  
Dardick Irving, 1993, Critical Reviews in Oral Biology and Medicine, V4, P639
[3]   Expression and function of EGF-related peptides and their receptors in gynecological cancer - From basic science to therapy? [J].
Ebert, AD ;
Wechselberger, C ;
Martinez-Lacaci, I ;
Bianco, C ;
Weitzel, HK ;
Salomon, DS .
JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH, 2000, 20 (01) :1-46
[4]  
Grizzle William E., 1998, V14, P143
[5]  
Grizzle William E., 1998, V14, P161
[6]   HER-2/NEU EXPRESSION - A MAJOR PROGNOSTIC FACTOR IN ENDOMETRIAL CANCER [J].
HETZEL, DJ ;
WILSON, TO ;
KEENEY, GL ;
ROCHE, PC ;
CHA, SS ;
PODRATZ, KC .
GYNECOLOGIC ONCOLOGY, 1992, 47 (02) :179-185
[7]   Environmental factors and the risk of salivary gland cancer [J].
HornRoss, PL ;
Ljung, BM ;
Morrow, M .
EPIDEMIOLOGY, 1997, 8 (04) :414-419
[8]   EXPRESSION OF C-ERBB-2 ONCOPROTEIN IN SALIVARY-GLAND TUMORS - AN IMMUNOHISTOCHEMICAL STUDY [J].
KERNOHAN, NM ;
BLESSING, K ;
KING, G ;
CORBETT, IP ;
MILLER, ID .
JOURNAL OF PATHOLOGY, 1991, 163 (01) :77-80
[9]  
KIRBY RE, 1995, ARCH SURG-CHICAGO, V130, P69
[10]   Immunohistochemical expression of transforming growth factor alpha and epidermal growth factor receptor in gastrointestinal carcinoids [J].
Krishnamurthy, S ;
Dayal, Y .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1997, 21 (03) :327-333